#antibodies

Extra vaccine doses, monoclonal antibodies and antivirals can help prevent severe illness.

Two treatment approaches using donor or engineered NK cells led to remission in people with lymphoma and leukemia.

Researchers urge survivors and their doctors to monitor heart health.

A new type of treatment uses antibodies to deliver cancer-fighting drugs directly to tumors.

Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.

New discoveries may show a way to save bone marrow cells and blood stem cells following chemotherapy.

Cancer patients undergoing treatment and those with suppressed immune systems eye the future—and the COVID pandemic’s wane—warily.

Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.

The findings suggest boosters not only lengthen immunity but help broaden and strengthen the immune response.

Evidence is growing that contracting SARS-CoV-2 is generally as effective as vaccination at preventing COVID-19.

People who received the Moderna COVID-19 vaccine had strong immune memory of SARS-CoV-2 six months after vaccination.

This is a good time to talk about how sleep can affect the body’s immune response to a vaccination.

Bamlanivimab and etesevimab may be given to people with mild to moderate COVID-19 who are at high risk for progression to severe disease.

More than 95% of people who recovered from COVID-19 had durable immune system memory up to eight months after infection.

Another vaccine, from Novavax, was 89% effective in a U.K. trial, but both were less potent against the South African coronavirus mutation.

Long-lived memory immune cells continue to provide protection even after antibody levels drop.